NCT03518957

Brief Summary

Exercise in early breast cancer patients has the potential to improve depression, anxiety, fatigue, quality of life and even survival. The effects of exercise may come about by way of changes in weight, immune markers and telomere length, but data on this so far has not been conclusive. To better understand the physical, psychological, and biological effects of exercise on breast cancer survivorship, the investigators propose to perform a phase III randomized controlled trial of a 12-week exercise intervention program versus usual care in early stage breast cancer patients, and will follow up the patients prospectively for 5 years, with serial assessment of physical and functional activity, QoL, depression and anxiety scores, telomere length and plasma immune markers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
304

participants targeted

Target at P25-P50 for phase_3 breast-cancer

Timeline
Completed

Started Mar 2015

Longer than P75 for phase_3 breast-cancer

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2015

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 8, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
Last Updated

May 14, 2018

Status Verified

February 1, 2018

Enrollment Period

6.8 years

First QC Date

March 27, 2018

Last Update Submit

May 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improved mental health

    Based on the HADS (Hospital Anxiety and Depression Scale) questionnaire, we define a score of ≥8/21 as caseness for anxiety or depression

    12 months

Secondary Outcomes (1)

  • Adherence rate

    16 weeks

Study Arms (2)

Exercise intervention

EXPERIMENTAL

Patients who are randomised to this arm will be enrolled to the exercise programme.

Behavioral: Exercise

Non-exercise

NO INTERVENTION

Patients who are randomised to the non-exercise group can continue their daily and physical activities as they normally would.

Interventions

ExerciseBEHAVIORAL

Week 1: Patients will undergo an introductory session where the occupational therapist will assess the general condition and physical fitness of the subjects. Week 1 to Week 12: Group exercise sessions supervised by a physiotherapist, twice per week, each session lasting 1 hour, with no more than 8 participants in each group exercise session. The exercise regimen for each session will be personally tailored for the subjects, and will include stretching, cardiovascular and strength training, and cooling down exercises. Week 12 onwards: Patients will receive phone calls- monthly for the first 6 months and then 3 monthly up to the 2-year mark, to encourage them to continue with their exercise regimen at home.

Exercise intervention

Eligibility Criteria

Age21 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly females will be included, as this is a study on breast cancer
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • Age 21-70 years
  • Histological or cytological diagnosis of breast carcinoma
  • Stage I-III breast cancer
  • Has undergone curative breast cancer surgery with no clinically measurable tumor
  • Between 4-12 weeks from the last adjuvant radiotherapy or chemotherapy session, if given, whichever is later. Patients who do not receive adjuvant chemotherapy or radiotherapy can be enrolled and will be randomized within 4-12 weeks of breast cancer surgery.
  • Able to sign informed consent
  • Able to adhere to study procedures

You may not qualify if:

  • Cardiovascular, respiratory, or musculoskeletal problems that preclude moderate physical activity
  • Major medical problems deemed by the investigator to be unsuitable for enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

National University Hospital, Singapore

Singapore, 119228, Singapore

RECRUITING

Tan Tock Seng Hospital

Singapore, 308433, Singapore

RECRUITING

Ng Teng Fong General Hospital

Singapore, 609606, Singapore

RECRUITING

Related Publications (2)

  • Carayol M, Bernard P, Boiche J, Riou F, Mercier B, Cousson-Gelie F, Romain AJ, Delpierre C, Ninot G. Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol. 2013 Feb;24(2):291-300. doi: 10.1093/annonc/mds342. Epub 2012 Oct 5.

    PMID: 23041586BACKGROUND
  • Kolden GG, Strauman TJ, Ward A, Kuta J, Woods TE, Schneider KL, Heerey E, Sanborn L, Burt C, Millbrandt L, Kalin NH, Stewart JA, Mullen B. A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psychooncology. 2002 Sep-Oct;11(5):447-56. doi: 10.1002/pon.591.

    PMID: 12228878BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2018

First Posted

May 8, 2018

Study Start

March 12, 2015

Primary Completion

December 20, 2021

Study Completion

December 20, 2025

Last Updated

May 14, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations